Overview
Timothy Ernst is an Oncologist in Natick, Massachusetts. Dr. Ernst is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. His top areas of expertise are Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Paget Disease of the Breast. Dr. Ernst is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Dana-Farber Cancer Institute, Inc.
Ursula Matulonis is an Oncologist in Boston, Massachusetts. Dr. Matulonis is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Tubal Ligation. Dr. Matulonis is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Joyce Liu is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. Her top areas of expertise are Ovarian Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Testicular Yolk Sac Tumor. Dr. Liu is currently accepting new patients.
The General Hospital Corporation
Richard Penson is an Oncologist in Boston, Massachusetts. Dr. Penson is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Gastrostomy. Dr. Penson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Inflammatory Breast CancerDr. Ernst isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Ernst isDistinguished. Learn about Lung Cancer.
- Myelodysplastic Syndrome (MDS)Dr. Ernst isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaDr. Ernst isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Ovarian CarcinosarcomaDr. Ernst isDistinguished. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Ernst isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Ernst isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Ernst isAdvanced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Ernst isAdvanced. Learn about Breast Cancer in Men.
- Chronic B-Cell Leukemia (CBCL)Dr. Ernst isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ernst isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Ernst isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Ernst isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Ernst isExperienced. Learn about Anaplastic Large Cell Lymphoma.